Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03606382 · ClinicalTrials.gov registry record
Collection of Clinical Specimens From Volunteers for Assay Development
A clinical trial of Acute Respiratory Infection, sponsored by Inflammatix.
- Completed
- Registry status
- 6
- Enrollment target
- 1
- Study location
NCT03606382: Completed study of Acute Respiratory Infection, sponsored by Inflammatix.
NCT03606382 is a study of Acute Respiratory Infection that has completed, run by Inflammatix. The registered enrollment target is 6 participants, below the 330-participant average among 7 other Acute Respiratory Infection trials with a reported enrollment target (98% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT03606382, a study of Acute Respiratory Infection, has completed, sponsored by Inflammatix.
- COMPLETED
- Registry status
- 6 participants
- Enrollment target
- 1
- Study location
Study Summary
This study will analyze gene expression data from various biological specimens collected from voluntary participants.
Primary Outcome
Blood collection, upper respiratory specimens including. nasal swabs, nasal washes, nasopharyngeal swabs, buccal swabs, buccal washes), sputum, saliva, urine and a skin/soft-tissue specimen (dermal).
Conditions Studied
Interventions
- DIAGNOSTIC_TEST HostDx Fever Test
- DIAGNOSTIC_TEST HostDx Sepsis Test
Study Locations (1)
California
- Inflammatix, Inc. - Burlingame
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 6 participants |
| Start Date | 2018-04-01 |
| Est. Completion | 2019-05-01 |
What the finished NCT03606382 record still lists
NCT03606382 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 6 participants, a relatively small participant target, below the 330-participant average among 7 other Acute Respiratory Infection trials with a reported enrollment target (98% lower).
The record links to 1 condition, with Acute Respiratory Infection appearing as the primary indexed condition, and to 2 interventions - of which HostDx Fever Test is the first listed.
NCT03606382 reports a single indexed study location in California.
Frequently Asked Questions
What is clinical trial NCT03606382 about?
NCT03606382 is a clinical study titled "Collection of Clinical Specimens From Volunteers for Assay Development". This study will analyze gene expression data from various biological specimens collected from voluntary participants.
What is the current status of trial NCT03606382?
This trial is currently completed. The enrollment target is 6 participants. The study started on 2018-04-01. Estimated completion is 2019-05-01.
What conditions does trial NCT03606382 study?
This clinical trial studies the following conditions: Acute Respiratory Infection.
What interventions are being tested in trial NCT03606382?
The interventions under investigation include: HostDx Fever Test (DIAGNOSTIC_TEST), HostDx Sepsis Test (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03606382?
This trial is sponsored by Inflammatix, which has 5 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03606382 being conducted?
This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Acute Respiratory Infection
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
ORCHARDS-AIR Study
RECRUITING · NA
-
Rapid Diagnosis of Viral Acute Respiratory Infection to Decrease Unnecessary Antibiotic Utilization in the Emergency Department (RADIATE)
ACTIVE NOT RECRUITING · NA
-
Prophylaxis and Treatment of COVID-19
COMPLETED
-
Kent State University / Price Chopper Employee Wellness Study
COMPLETED · NA
-
Outcomes Related to COVID-19 Treated With Hydroxychloroquine Among In-patients With Symptomatic Disease
COMPLETED · Phase 3
-
Meditation and Exercise for Prevention of Acute Respiratory Infection
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI